DEV

You are viewing our development site. Please share feedback with support@dosevault.ai or on our Discord server. See what is new in the changelog.

Performance

Ipamorelin + Tesamorelin Blend

Investigational blend pairing a clean GHRP (ipamorelin) with a stable GHRH (tesamorelin).

Molecular Profile
linear
49 AA Sequence
Formula
ipamorelin + tesamorelin combo
Chain length
49 aa
Onset and duration

Acute growth-hormone pulse within roughly 30 to 60 minutes of dosing; body-composition effects build over weeks.

Storage and reconstitution

Store the lyophilized powder refrigerated (2 to 8 C), or frozen for long-term storage, protected from light. After reconstitution with bacteriostatic water, keep refrigerated and use within about 4 weeks.

Clinical Evidence

What the literature says

Scientific Overview

Compounding pharmacies began offering ipamorelin + tesamorelin blends in 2024-2025 after the FDA tightened on CJC-1295. Tesamorelin is FDA-approved (Egrifta) for HIV-associated lipodystrophy, providing a stable GHRH backbone with documented visceral-fat reduction; ipamorelin contributes a clean ghrelin-mimetic pulse. Limited combination-trial data exists.

Research Guide

How users approach this compound

The following reflects patterns observed in research literature and community protocols. This is not medical advice and does not constitute a clinical recommendation.

Research Protocols

Common Dosages

Stack

200 mcg + 1 mg
Daily SC

AM or pre-bed; 8-12 week cycles

Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Key Research Benefits

  • Synergistic GH pulse
  • Visceral fat targeting via tesamorelin
  • Cleaner sides than CJC blends

Potential Side Effects

Injection-site reactions
Possible water retention
Insulin resistance with chronic use

Labs to monitor

Educational context only, not a testing mandate. Any bloodwork decisions belong with your clinician.

  • IGF-1: Primary downstream marker of growth-hormone-axis activity.
  • Fasting glucose / HbA1c: GH-axis stimulation can reduce insulin sensitivity over time.

Dose Calculator

Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

48 Units

or 0.48 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Ipamorelin + Tesamorelin Blend by goal

Read Ipamorelin + Tesamorelin Blend's profile filtered through specific research goals.

Related Tools

Not medical advice

Information on DoseVault is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified healthcare provider.